Jubilant Life Sciences has received an approval to consolidate the company’s Pharmaceutical Segment under two separate verticals, one comprising of Active Pharmaceuticals Ingredients, Solid Dosage Form, Radio Pharmaceuticals, Allergic Extracts, Sterile Injectable and Ointment, Cream and Liquid businesses (Pharma Business) and other Drug Discovery Businesses, subject to all necessary approvals/ consents/ permissions and sanctions. The board of directors at its meeting held on May 28, 2013 has approved for the same.
The board has also approved to constitute a committee to decide the modalities of consolidating the Pharma Business and the Drug Discovery Business under two separate subsidiaries of the company and explore, identify and implement the options and opportunities of raising money by listing the Pharma business for its growth and reduction of overall consolidated debt of the company.
Jubilant Life Sciences is an integrated Pharmaceuticals and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution provider out of India.
